AMPLIA THERAPEUTICS AND AUSTRALIA NEW ZEALAND GYNAECOLOGICAL ONCOLOGY GROUP (ANZGOG) ANNOUNCE OVARIAN CANCER STUDY Media Release - 8 May 2026 Highlights Amplia and ANZGOG enter into agreement to conduct a clinical study in ovarian cancer evaluating narmafotinib in [...]
More than half of women diagnosed will die — the ovarian cancer reality Australia can’t ignore Ovarian cancer remains the most lethal cancer affecting women, yet it continues to receive a fraction of the attention and investment [...]
Blood test offers hope for more effective ovarian cancer treatment Media Release - 12 November 2025 New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment [...]
ANZGOG is pleased to announce the successful completion of patient accrual for the ECHO clinical trial. ECHO, ANZGOG’s first ever exercise-intervention trial, has now closed to recruitment after recruiting 524 participants since the study opened [...]
ANZGOG's ovarian cancer studies, ICON9 and STICs & STONEs have both closed to recruitment. ICON9 ICON9 is led by Principle Investigator, Prof Linda Mileshkin ICON9 is an international phase III randomised study [...]
ANZGOG's new podcast 'On the Down Low' won 'Best New Podcast' at the Australian Podcast Awards, which celebrate the nation’s best audio talent and creativity. The podcast features raw and inspiring stories from women with ovarian [...]
Jenny and her daughter Kathryn are both advocates for ANZGOG’s Survivors Teaching Students (STS) program in QLD, Australia and New Zealand respectively. “One of the first things I wanted to do when diagnosed was [...]
EMBRACE is a Phase II clinical trial of the PARP inhibitor, olaparib, in HR-deficient metastatic breast and relapsed ovarian cancer in patients without germline mutations in BRCA1 and BRCA2. Dr Katrin Sjoquist, Medical Oncologist [...]
In this interview, we learn how newly appointed ANZGOG Chair, Prof Clare Scott's experiences in translational research is shaping the way she approaches her new role, what her goals and aspirations are for ANZGOG, and we discover [...]
To mark International Women’s Day, ANZGOG celebrates the women leading gynaecological cancer research in a Q&A with Professor Anna deFazio and Associate Professor Caroline Ford Professor Linda Mileshkin and Associate Professor Caroline Ford [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2026 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
